Pharmatech Associates and InQui Capital of Hong Kong announced the Pharmatech Connect programme, a collaboration bringing development opportunities to early stage life science technology companies in the areas of investments, market expansion and strategic alliances worldwide.
Pharmatech Connect is a programme created by Pharmatech Associates to provide early to mid-stage life sciences companies with financial resources to enable and accelerate development. The program services include identification and introduction of investors to cover the full range of development costs encompassing expertise in: global regulatory, technical development, manufacturing and compliance requirements, strategic partnering, business development and global healthcare investment services.
Pharmatech Associates provides consulting and services to the regulated life science industry. Pharmatech’s services cover four spheres of technical expertise that are necessary throughout the complete product development lifecycle: Product and process development, compliance, regulatory, and validation.
InQui Capital Ltd. is a Hong Kong-based consulting and investment firm focusing on life science-related sectors. InQui serves as a gateway between China and the West by helping small to mid-size companies find strategic partners both locally and globally.
Subscribe to PharmaTutor News Alerts by Email >>
